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Background. Recent studies in patients with acute renal fail- to assure that all patients on CHD receive at least a
ure (ARF) have shown a relationship between the delivered minimum dose of dialysis, currently set as a Kt/V of 1.2dose of dialysis and patient survival. However, there is cur-
or more [4]. Although there is currently no consensusrently no consensus on the appropriate method to measure the
on the appropriate dose of hemodialysis (HD) therapydose of dialysis in ARF patients. In this study, the dose of
dialysis was measured by blood- and dialysate-based kinetic for acute renal failure (ARF) patients, recent studies
methods in a group of ARF patients who required intermittent have also shown an inverse relationship between the
hemodialysis. delivered dose of dialysis and patient survival (abstract;Methods. Treatments were performed using a Fresenius 2008E
Schiffl et al, J Am Soc Nephrol 8:290A, 1997) [5]. In thevolumetric hemodialysis machine with the ability to fractionally
collect the spent dialysate. Single-, double-pool, and equili- absence of a defined target for optimal dose of dialysis
brated Kt/V were determined from the pre-, immediate post-, in ARF, these studies suggest that, at the very least, the
and 30-minute post-blood urea nitrogen (BUN) measurements. dose of dialysis should be measured in such patients
The solute reduction index was determined from the collected
(abstract; Schiffl et al, ibid) [5].dialysate, as well as the single- and double-pool Kt/V.
Kt/V and the URR are two blood-based methods usedResults. Forty-six treatments in 28 consecutive patients were
analyzed. The mean prescribed Kt/V (1.11 6 0.32) was signifi- to determine solute removal and are accepted methods
cantly greater than the delivered dose estimated by single-pool for measuring the dialysis dose in CHD patients [6, 7].
(0.96 6 0.33), equilibrated (0.84 6 0.28), and double-pool (0.84 6 However, their validity in ARF patients has not yet been0.30) Kt/V (compared with prescribed, each P , 0.001). There
confirmed. The measurement of Kt/V is based on severalwas no statistical difference between the equilibrated and dou-
patient- and dialysis-related assumptions, such as steady-ble-pool Kt/V (P 5 NS). The solute removal index, as deter-
mined from the dialysate, corresponded to a Kt/V of 0.56 6 state urea nitrogen generation and a relatively fixed vol-
0.27 and was significantly lower than the single-pool and dou- ume of urea distribution, as well as consistent dialyzer
ble-pool Kt/V (each P , 0.001). and vascular access performance [8–10]. These assump-Conclusion. Blood-based kinetics used to estimate the dose
tions may be substantially altered in ARF patients, andof dialysis in ARF patients on intermittent hemodialysis pro-
recent data obtained in ARF patients have shown thatvide internally consistent results. However, when compared
with dialysate-side kinetics, blood-based kinetics substantially the delivered dose of dialysis is much less than the pre-
overestimated the amount of solute (urea) removal. scribed dose [11]. Therefore, prior to establishing an
appropriate dose of dialysis in ARF, the methods avail-
able must be evaluated and validated.
The delivered dose of dialysis, as measured by Kt/V The solute reduction index (SRI) is another method
or the urea reduction ratio (URR), has a strong impact of measuring the delivered dose of dialysis and is consid-
on the outcome of patients on chronic hemodialysis ered by many to be the gold standard for measuring the
(CHD) [1–3]. This has resulted in the establishment of dose of dialysis [12]. SRI measures the amount of urea
guidelines by the Renal Physician Association (RPA) removed during an HD treatment, whereas Kt/V or
URR measures the fractional change in blood urea con-
centration. In well-dialyzed, stable CHD patients, theKey words: hemodialysis, urea reduction ratio, Kt/V, solute reduction
index, mortality and dialysis, dialysis dose. SRI and the equilibrated Kt/V (eKt/V) have been found
to be equivalent [12–14]; however, the advantage of usingReceived for publication June 26, 1998
SRI over Kt/V is that SRI is not influenced by intercom-and in revised form October 22, 1998
Accepted for publication November 4, 1998 partmental distribution, the mode of therapy (conven-
tional vs. high-flux HD), or the type of kinetics employed 1999 by the International Society of Nephrology
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(single vs. two-pool) [12, 15]. Because of these factors, a venous pressure of less than 200 mm Hg and an arterial
SRI may be a more accurate measurement of the deliv- pressure of no less than a negative 200 mm Hg. At the
ered dose of dialysis in ARF than is Kt/V. end of the treatment, the patient’s weight was obtained,
In this study, we systematically measured the dose of and the actual dialysis time was recorded. The net vol-
dialysis in a group of ARF patients requiring HD. We ume removed by ultrafiltration was recorded.
evaluated multiple methods of blood-based kinetics and Blood sampling. Pretreatment blood urea nitrogen
compared them with dialysate-based kinetics for further (BUN) samples were obtained in all patients within 5 to
validation. We also identified factors that contributed to 10 minutes prior to the initiation of the treatment. To
differences between the blood-based and dialysate-based determine the in vivo dialyzer urea clearance during the
kinetics. treatment, the afferent (Ci) and efferent (Co) dialyzer
BUN levels were simultaneously drawn at 15 minutes
and 180 minutes following the initiation of treatment,METHODS
and the blood pump speeds were recorded. A post-treat-Patient population
ment BUN was obtained at the end of each treatment
From December 1, 1996, until April 30, 1997, all pa- using the slow-flow method [16]. Specifically, the blood
tients over the age of 18 who were treated with intermit- pump speed was decreased to 50 ml/min for two minutes
tent HD (IHD) for ARF at the Vanderbilt University before the sample was obtained. For 34 of the 46 treat-
Medical Center (VUMC) and the Maine Medical Center ments (74%), BUN levels were also obtained 30 minutes
(MMC) were eligible for inclusion in this study. The pa- after the completion of the dialysis treatment. The sam-
tients were excluded from the study if they had a urine ple was analyzed in triplicate with a Beckmant BUN
output of more than 400 ml/day, inadequate data acquisi- Analyzer 2 utilizing urea plasma standards. For samples
tion, unavailability of an appropriately equipped HD not analyzed within two hours of completing the treat-
machine, concomitant plasmapheresis treatment, or treat- ment, the plasma was placed in a nonsterile, polypropyl-
ment durations of less than three hours, generally be- ene vial and was stored at 2708C.
cause of hemodynamic instability. The study was a pro- Fractional dialysate sampling. The HD machines used
spective, observational design and was approved by the for the study were equipped with the Freseniust Dialy-
institutional review board (IRB) at both study centers; sate Sampling Module (DSM) for quantitative determi-
informed consent was obtained for the HD procedure.
nation of the total solute removal during the HD session.
Studies have shown that continuous fractional samplingHemodialysis treatment
of dialysate with the DSM reflects total dialysate collec-All studied HD treatments were performed with a
tion for urea removal [15, 17, 18]. A 0.45 mm filter (Lidat)Fresenius 2008E volumetric HD machine with the ability
was placed at the sampling port, and the effluent wasto collect the spent dialysate fractionally. All treatments
collected into a 2 liter polypropylene-graduated cylinder.were done with new biocompatible membranes (Freseni-
To decrease contamination with urease-producing bacte-ust F-80A or Torayt B2-1.5H) that were not reused and
ria, the cylinders were cleaned and stored in a 0.5%used bicarbonate dialysate. All patients were dialyzed
bleach solution when not in use. The effluent rate and thevia a percutaneous, dual-lumen, polyurethane dialysis
total volume collected corresponded to the ultrafiltrationcatheter (Quintont or VasCatht) placed in a central
rate and volume, respectively. After the HD session, thevein (femoral, internal jugular, or subclavian).
sample was well mixed, and the urea concentration was
determined within two hours of sampling. The samplesStudy design
were analyzed in triplicate using a Beckmant BUN Ana-General. All physician orders, including the initiation
lyzer 2 utilizing aqueous urea standards. For samples notand the timing of HD, were written by the attending
analyzed within two hours of completing the treatment,nephrologist directly caring for the patient. No change
the sample was again filtered through a 0.45 mm filter,in patient care, including the initiation of HD or the
placed into a nonsterile, polypropylene vial, and stored atnumber of times dialyzed per week, was done for study
2708C. The total volume of dialysate for each treatmentpurposes. Prior to each HD treatment, the following
session was determined by multiplying the dialysateprescription parameters were obtained: the prescribed
pump speed by the treatment duration and adding thistime, dialysate and blood flows, and the patient’s height
to the amount of dialysate collected. The total volumeand weight. In order to calculate the delivered dose of
of dialysate was then used to determine the total amountdialysis, the blood and dialysate pump speeds were re-
of urea removed during the treatment session.corded every 15 minutes, and their respective time-aver-
Recirculation studies. Recirculation rate was mea-aged value was calculated. The time-averaged value was
sured by a 3-BUN method using the low blood flowused in the subsequent calculations. Arterial and venous
technique [16], as well as the ultrasound dilution methodpressures were monitored throughout the procedure,
and the blood pump speeds were adjusted to maintain (Transonics Systems, Inc., Ithaca, NY, USA). Both mea-
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Table 1. Patient demographicssurements were done approximately 30 minutes after
the start of dialysis with ultrafiltration turned off. No Age 58.6620.3
Male 15 (54%)saline or other fluids were administered for at least 10
White 23 (82%)minutes prior to blood sampling. For the 3-BUN method, Treatments per patient 1.6160.88 (Range 1–4)
blood samples for urea testing were drawn from the Total treatments performed in ICU 37 (80%)
Number on ventilator 25 (75%)arterial and venous bloodlines simultaneously at a blood
Number on blood pressure support 19 (51%)flow rate of 250 ml/min. Immediately thereafter, a “sys- Average blood pressure
temic” blood sample was obtained by reducing the blood ICU 120/57 (MAP 5 78642)
Non-ICU 146/82 (MAP 5 103656)flow rate to 50 ml/min and drawing from the arterial
Abbreviations are: ICU, intensive care unit; MAP, mean arterial pressure.line. Following the 3-BUN measurement, a recirculation
rate by ultrasound dilution was carried out per manufac-
turer’s instructions.
Fiber bundle volume. The fiber bundle volume of the
of the membrane obtained at 15 minutes into the treat-dialyzers was determined pretreatment and posttreat-
ment session. The SRI for the measured Kt/V (SRIKt/v)ment with a DRS-4 machine (Seratronicst) as per the
values were determined by the formulae, as describedmanufacturer’s instructions.
by Bankhead et al [13].Quantitation of dose: Blood-side kinetics. For each
Urea nitrogen appearance (UNA). A component oftreatment, a prescribed and predicted Kt/V was deter-
the post-treatment BUN level may be comprised of ureamined (the formulas are in the Appendix). The pre-
generated by catabolism and may be substantial in cata-scribed Kt/V was determined from the dialysis prescrip-
bolic ARF patients. Therefore, in a subgroup of treat-tion time, the pretreatment total body water (TBW),
ments (N 5 15), the post- and 30-minute post-BUN levelsdetermined as a fraction of the patient’s weight (0.6 for
were adjusted for UNA as described [20]. The correctedmales and 0.55 for females), and the in vitro dialyzer
BUN was then used to determine the new spKt/V, eKt/V,clearance, which was obtained from the manufacturers
dpKt/V, and the SRI as described earlier here in thedata. This was an attempt to duplicate the process of de
blood- and dialysate-side kinetic sections.novo prescription of dialysis dose in an ARF patient.
Statistical analysis. Demographic data and variousThe predicted Kt/V for each treatment was determined
treatment characteristics were tabulated. Differences be-from the actual treatment time, the post-treatment TBW,
tween the study variables, for example, prescribed andas determined from the patient’s weight as described
delivered blood flows, dialysate flows, and treatmentearlier here, and substituting the measured in vivo dia-
times, were evaluated by a paired t-test. The percentagelyzer urea clearance for the in vitro dialyzer clearance.
of differences between the dialysate- and the blood-We used several methods to quantitate the dose of
based kinetics, for example, SRIspKt/V or SRIdpKt/V anddialysis, based on the methodology used for CHD. To
SRIDialysate, were determined. Univariate associations be-determine the delivered dose of dialysis for each treat-
tween the percentage difference and various patient andment, a single-pool Kt/V (spKt/V) and an eKt/V were
treatment variables, for example, age, gender, weight,calculated by the Daugirdas II equation and the Daugir-
race, type of dialyzer used, the location of the catheter,das correction, respectively [19]. A double-pool Kt/V
the center that the patient dialyzed at (VUMC or MMC),(dpKt/V) was calculated by substituting the post-BUN
and the use of anticoagulation (yes or no), were evalu-concentration in the Daugirdas II formula with the 30-
ated by a general linear model [21, 22]. All significantminute post-BUN concentration. URR was also deter-
univariate factors, as well as the interaction factor be-mined by using the predialysis and the immediate post-
tween the gender and the weight, were considered in theBUN values as described in the Methods section [19].
multivariate general linear model analysis [21, 22].Quantification of dose: Dialysate-side kinetics. The
All tests of significance were two sided, and differencesSRI (SRIDialysate) was determined by a modification of
were considered statistically significant when the P valuethe formula described by Keshaviah and Star [12]. The
was less than 0.05. All data were expressed as means 6amount of urea present in the dialysate was determined
1 sd. SAS version 6.12 was used for all analysis.by multiplying the total volume of dialysate for that
treatment by the urea concentration in the collected dial-
ysate. The total body concentration of urea was deter- RESULTS
mined by multiplying the pretreatment BUN level by
Patient demographicsthe TBW. The TBW was determined anthropometrically
Forty-six treatments in 28 consecutively dialyzed pa-by multiplying the patient’s predialysis weight by a frac-
tients had complete data and were used for further analy-tion (0.6 for males and 0.55 for females), as well as
sis. Table 1 summarizes the demographic data for thekinetically by dividing the spKt/V and dpKt/V by the
duration of the HD session and the in vivo urea clearance study patients. Fifty-four percent of the studied patients
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Table 2. Treatment characteristics
Prescribed Delivered
Time minutes 224639 223640
Blood flow ml/min 290651 260651a
Dialysate flow ml/min 532694 533694
a P , 0.05, paired, 2 tail t-test, Prescribed vs. Delivered
Table 3. Anticoagulation usage
Number of treatments
Saline only 15
Heparin
Standarda 18
Tightb 10
Citratec 3
Fig. 1. Dialyzer urea clearance for the Fresenius F-80A and Toraya Standard heparin: Patients received at least 3,000 units during the treatment
B2-1.5H at 15 and 180 minutes after the initiation of therapy. Valuessession
are mean 6 1 sd.b Tight heparin: Patients received less than 2,000 units during the treatment
session
c Regional citrate anticoagulation: Protocol as per Pinnick et al [28]
261 6 51 ml/min, respectively. As shown in Figure 1,
there was no statistical difference between the urea clear-
were male, and 82% were white. Eighty (80%) of the ances of the Freseniust F-80A and the Torayt B2-1.5H
treatments were done in patients in the intensive care dialyzers at either 15 minutes or three hours (P 5 NS).
unit (ICU), and of those, a majority (75%) were on Finally, the fiber bundle volume in a subgroup of the
ventilator therapy. The average predialysis blood pres- dialyzers used (N 5 17) was measured pretreatment and
sure was 120/57 in patients in the ICU and 146/82 in post-treatment. As expected from the manufacturer’s
patients not in ICU. Twenty-eight (61%) of the treat- data, pretreatment, the Freseniust F-80A dialyzers fiber
ments were performed with a Freseniust F-80A dialyzer, bundle volume was larger than that of the Torayt
B2-1.5H (110.9 ml 6 3.4 ml vs. 82.1 ml 6 2.8 ml, respec-whereas 18 (39%) were performed with a Torayt
tively). However, neither dialyzer had a significant per-B2-1.5H dialyzer. Eighty percent of the patients were
centage change in fiber bundle volume during the treat-dialyzed three times per week, and 20% were dialyzed
ment session (Freseniust F-80A, 3.2 6 2.1% decrease,every other day.
Torayt B2-1.5H, 2.6 6 2.0% decrease). Therefore, at
the blood flows achieved in this study, there was noBlood-based kinetic analysis
significant difference in urea clearance between the high-Table 2 summarizes the treatment characteristics for
flux and the standard-flux dialyzer.all of the treatments. The delivered treatment time and
Figure 2 depicts Kt/V derived from pre-, post-, and 30-
dialysate flow rate were not significantly different from
minute post-BUN measurements. The mean prescribed
the prescribed values, whereas the delivered blood flow Kt/V for the studied treatments was significantly greater
was significantly less than the prescribed blood flow than the predicted and measured Kt/V, whether this
(260 6 51 ml/min vs. 290 6 51 ml/min). The anticoagula- was based on single-pool, equilibrated, or double-pool
tion usage is shown in Table 3. Thirty-one of the treat- calculations (each P , 0.001). The predicted Kt/V was
ments (64%) were performed with the use of either re- not significantly different from the spKt/V (1.00 6 0.36
gional (tight heparin and citrate) or systemic (standard vs. 0.96 6 0.33, P . 0.05) but was significantly higher
heparin) anticoagulation. Fifteen of the treatments than the equilibrated (0.84 6 0.28, P , 0.001) and the
(33%) were performed using saline flushes. dpKt/V (0.84 6 0.31, P , 0.001). The eKt/V and the
The dialyzer performance and the type of dialyzer dpKt/V were not numerically or statistically different.
used were also examined. The mean urea clearances The mean URR for the treatments was 54.1 6 12.0%.
were 218.0 6 41.8 ml/min at 15 minutes and 218.8 6 52.2
Urea nitrogen appearanceml/min at three hours, respectively (P 5 NS), demonstra-
ting that there was no decline in dialyzer performance To evaluate the influence that UNA rates may have
during the treatment session. The mean blood flows at on the post- and 30 minute post-BUN levels, the UNA
rates were calculated in a subgroup of treatments (N 515 minutes and three hours were 259 6 51 ml/min and
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Fig. 2. The calculated and measured Kt/V.
Values are mean 6 1 sd. Formulas as listed
in the Appendix. *P , 0.001 vs. prescribed
Kt/V. †P , 0.001 vs. predicted Kt/V.
15). These patient characteristics were similar to the 12.2%) and the SRIdpKt/V (54.9 6 12.9%; Fig. 3). Of note,
the SRIDialysate corresponded to a Kt/V of 0.56 6 0.27.overall study group. The UNA rates were calculated
To determine the potential factors that may accountfrom the post-treatment BUN of one HD session and
for the discrepancy between the SRIDialysate and thethe pretreatment BUN of the following HD session. The
SRIKt/V, we evaluated the percentage difference betweenmean UNA for these treatments was 17.3 6 5.18 g/day
the SRIDialysate and the SRIKt/V with regards to several(range, 7.20 to 26.49 g/day) and 2.85 6 0.94 g during
patient and treatment variables. When the SRIDialysate wasthe treatment session (range, 1.20 to 4.62 g during the
compared with the SRIspKt/V and the SRIdpKt/V, a signifi-treatment session). The correction of the BUN by each
cantly greater percentage difference was observed inpatient’s UNA during the dialysis session resulted in a
younger patients, heavier patients, females, and blackpercentage decrease of 1.24 6 0.94% and 1.07 6 0.88%
patients (all P , 0.02 by univariate analysis). The dia-for the immediate post- and 30-minute post-BUN, re-
lyzer used, the location of the catheter, the center wherespectively. This resulted in a percentage increase of 1.29 6
the patient was dialyzed, and the use of anticoagulation0.79%, 1.26 6 0.77%, and 1.22 6 0.88% for the spKt/V,
did not correlate with the observed difference (P . 0.05).eKt/V, and dpKt/V, respectively. Because the UNA did
Because gender and weight are correlated, for example,not significantly change the calculated Kt/V, the UNA
men tend to weigh more then women, a multivariatewas assumed not to impact appreciably these kinetic calcu-
analysis consisting of age, weight, race, and gender waslations and was not corrected for in other calculations.
done controlling for the interaction between weight and
gender. The patient’s weight was the only variable toRecirculation
retain statistical significance (P , 0.05 vs. SRIspKt/V andAverage recirculation rate in these catheters, mea-
P , 0.001 vs. SRIdpKt/V).sured by the 3-BUN method described previously was
9.22 6 2.15%. Similarly, an average recirculation rate of
8.17 6 7.1% was obtained using the ultrasound dilution DISCUSSION
method (P 5 NS). In CHD patients, there is a strong inverse correlation
between the delivered dose of dialysis and clinical out-
Solute reduction index come [1, 2, 7]. Recently, studies performed in ARF pa-
Solute reduction indexDialysate, determined from using tients have also shown this same inverse relationship
the TBW obtained by the anthropometric measurement between survival and the delivered Kt/V (abstract; Schiffl
and the kinetic volumes, were not statistically different et al, ibid) [5]. Paganini et al stratified their ARF patients
(SRIDialysate 5 40.7 6 15.7% by the anthropometric by an APACHE-like scoring system and noted that pa-
method, 40.1 6 16.8% by the single-pool and 37.2 6 tients who had received a higher dose of dialysis had a
16.7% by the double-pool determined volume). For that lower mortality rate [5]. In a more recent prospective
reason, the SRIDialysate as determined by the anthropomet- study, the mortality rate of ARF patients who received
ric estimation of TBW was used in further analysis. The a weekly Kt/V more than 6 was 16% significantly lower
than the 37% mortality rate observed in patients whoSRIDialysate was significantly lower than the SRIspKt/V (59.9 6
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onstrated by the close to identical values for eKt/V and
dpKt/V [19]. Similar results were also obtained when the
in vivo dialyzer function and the urea generation, factors
that may reduce the delivery of dialysis, were further
evaluated. Specifically, the dialyzer performance, as
measured by the in vivo urea clearance at the beginning
and end of dialysis, had no significant decline during the
treatment period, and there was only a trivial amount of
decrease in fiber bundle volume in the studied dialyzers.
(However, it must be noted that the fiber bundle volume
is measured after cleaning the dialyzer and therefore may
not represent the total bundle volume that was available
during the treatment session.) Finally, the patient’s cata-
bolic rates, as determined by the UNA, had no significant
influence on the determined Kt/V. Nevertheless, it must
Fig. 3. A comparison of the solute resolution index (SRI) as deter- be stressed that although these data confirm the internalmined from blood- or dialysate-based kinetics. From the blood-based
consistency of the kinetic modeling equation, they dokinetics, the SRI was determined from the single-pool and double-
pool Kt/V. From the dialysate-based kinetics, the SRI was determined not prove the validity of using Kt/V or blood-side kinetics
using the anthropometrically determined total body water. Values are as the optimal method of dialysis dose measurement inmean 6 1 sd. Formulas are listed in the Appendix. *P , 0.05 vs.
ARF (discussed later in this article).SRIDialysate.
Interestingly, there was no difference in the clearance
of urea between a high- and a low-flux dialyzer. This
was most likely due to the slow blood flows obtained
received a weekly Kt/V of less than 3 (abstract; Schiffl with the temporary catheters (average blood flow was
et al, ibid). 260 6 51 ml/min) because at low blood flows (for exam-
Despite this emerging awareness of the role of dialysis ple, #300 ml/min), the flux characteristics of small mole-
dose on outcome of ARF patients, there is currently no cules are more blood-flow dependent than surface-area
evident consensus on the appropriate dose of dialysis or dependent [27].
the best method for assessing it in ARF patients. This Other potential problems with this study include post-
may reflect the fact that attention to this issue has devel- HD BUN rebound and cardiopulmonary recirculation,
oped only recently, and the studies addressing it are small both of which may influence the post-treatment BUN
and preliminary. In addition, as pointed out recently by levels. These factors probably had little influence in this
Paganini, the validity of using Kt/V or URR in ARF study because first, all accesses used in the study were
has to be confirmed [23]. Although Kt/V is an accepted venovenous, and therefore there was no cardiopulmo-
method for determining the delivered dose of dialysis in nary recirculation [10]. Second, the slow-flow method
CHD patients, the assumptions that it is based on may was developed to diminish the effects of rebound when
not be applicable to ARF patients. These assumptions drawing the post-BUN sample [16].
include steady-state UNA, constant dialyzer clearance The extent of catheter recirculation (9.22 6 2.15% by
at a given blood and dialysate flow, and a “well-mixed” the 3-BUN and 8.17 6 7.1% by the ultrasound dilution
urea volume of distribution, identical to the TBW, with method) may explain some of the differences between
no compartmentalization of urea distribution [9, 10, 24– the prescribed and delivered doses of dialysis. However,
26]. The goal of this study was to evaluate these assump- because the method of drawing the post-BUN has been
tions in a systematic fashion and compare several blood- shown to decrease the effect of recirculation on the re-
based urea kinetic calculations within themselves for sults of kinetic modeling, recirculation should not affect
consistency, as well as against dialysate-based urea kinet- the differences between the various expressions of
ics, which is currently considered the gold standard for blood-side kinetics or explain the differences between
the measurement of the actual delivered dose of dialysis the blood-side and dialysate-side kinetics.
[12, 14]. The estimate of the dose of dialysis from the dialysate
Using blood-based kinetic modeling equations devel- measurement, that is, the SRIDialysate, was significantly less
oped for CHD patients, our results in patients in ARF than the dose estimated from changes in the blood urea
appear parallel to the observations noted for CHD pa- concentration, suggesting that the blood kinetics overes-
tients and are internally consistent. Thus, the difference timated the amount of solute removal, and the actual
between the single- and dpKt/V was 13 6 10%, similar delivered dose of dialysis was much less than anticipated
to that observed in CHD patients; in addition, the eKt/V in ARF patients. It is possible that there may have been
errors in the determination of the SRIDialysate, such as ancalculation accounted for the post-HD rebound, as dem-
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inadequate dialysate collection or methodological prob- may be related to an alteration of the distribution of
lems. However, the method used to collect the spent urea in the TBW of ARF patients.
dialysate has been shown in various studies to correlate
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This study confirms the results of a recent report from
our laboratory, which showed, in patients with ARF, a APPENDIX A. CALCULATIONS
large discrepancy between prescribed and delivered dose (1) Clearance
of dialysis, as well as the low dose of delivered dialysis, Dialyzer urea clearances 5 [ (CI 2 Co)/Ci] 3 Qb
(2) Total body waterusing urea reduction rate as an index of dialysis dose
(a) anthropometric 5 pretreatment weight 3 0.6 (males) or 0.55[11]. In an accompanying editorial, Paganini raised the (females)
question of whether “dialysis-dosing measurements used (b) Kinetic
(i) Single-pool V 5 (Dialyzer urea clearances at 15 min 3 t)/in the chronic patient reflect an accurate picture of acute
(spKt/V)dialysis delivery” [23].
(ii) Double-pool V 5 (Dialyzer urea clearances at 15 min 3
This study is an attempt to answer that question by t)/(dpKt/V)
(3) Quantitation of dosemeasuring some of the components of Kt/V (namely t,
(a) Prescribed Kt/V 5 [(in vitro urea clearance) 3 prescribedK, and its potential variation during dialysis), the influ-
time)]/pre-TBW
ence of recirculation from the use of catheters as blood (b) Predicted Kt/V 5 (Dialyzer urea clearances at 15 min 3 t)/
access devices, and by calculating the potential influence post-TBW
(c) Delivered Kt/Vof high urea generation in these catabolic patients. We
(i) Single-pool Kt/V 5 2ln [(R1 2 (0.008 3 t)) 1 (4 2also measured the potential effect of high urea rebound (3.5 3 R1))] 3 UF/Post-weight
in ARF patients [23]. The relatively small difference (ii) Equilibrated Kt/V 5 spKt/V 2 (0.47 3 spK/V) 1 0.02
(iii) Double-pool Kt/V 5 2 ln [(R2- (0.008 3 t)) 1 (4 2between single-pool, double-, and eKt/V in our measure-
(3.5 3 R2))] 3 UF/Post-weightment suggests that this may not be an important cause
(d) URR
of low delivered dose of dialysis. This is also confirmed (i) URR 5 (1 2 R1) 3 100%
by the even lower dose of dialysis calculated by the (ii) 30 minute URR 1 (1-R2) 3 100%
(e) Solute reduction indexdialysate urea collection in this study.
(i) SRIDialysate 5 Total urea in dialysate (g)/(pre-BUN (g/liter) 3Finally, the estimation of the patient’s TBW would (TBW) 3 100%
also influence the SRIDialysate, as well as the blood-side (ii) SRIKt/V 5 1-e2Kt/V 3 100
(4) Urea nitrogen appearancekinetic calculation [23]. The patient’s volume of urea
(a) UNA 5 [(BUN2 2 BUN1) 3 0.006) 3 wt2) 1 (wt2 2 wt1)distribution was assumed to be evenly dispersed and
(BUN2/100)]/Interdialytic time
equal to the patient’s TBW, as has been shown in CHD (b) Correction of the post-BUN for urea generation
patients [8]. Currently, there are no studies that have Corrected post-BUN 5 post-BUN 2 [(UNA/t)]/post-TBW)
directly determined the TBW or the distribution of urea
in ARF patients, and this may be a potential explanation APPENDIX B. ABBREVIATIONS
of the disparity between the blood- and dialysate-based
Abbreviations used in this article are: BUN, blood urea nitrogen;
kinetics. BUN1, post-treatment BUN (g/liter) of the studied HD session; BUN2,
In summary, when compared with dialysate-based ki- pretreatment BUN (g/liter) of the next HD session; Ci, BUN level
drawn for the afferent dialysis tubing; Co, BUN level drawn from thenetics, blood-based kinetics significantly overestimate
efferent dialysis tubing; HD, hemodialysis; post-TBW, post-treatmentthe amount of solute (urea) removal, and in both cases, total body water as determined by the anthropometric method; Qb,
blood-based kinetics indicate that the dose of delivered blood pump speed (ml/min); R1, post-treatment BUN/pretreatment
BUN; R2, 30-minute post-treatment BUN/pretreatment BUN; spKt/V,dialysis is substantially lower than those delivered to
single-pool Kt/V; SRI, solute reduction index; t, treatment time (hours);CHD. In addition, the discrepancy between those types
TBW, total body water; UF, amount ultrafiltered (liters); UNA, urea
of measurement was not due to dialyzer function, post- nitrogen appearance; URR, urea reduction ratio; Wt1, postweight (kg)
of the studied HD session; Wt2, preweight (kg) of the next HD session.HD BUN rebound, or the patient’s catabolic rate, and
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